Schrodinger Inc
$ 14.60
3.18%
11 Jun - close price
- Market Cap 1,057,298,000 USD
- Current Price $ 14.60
- High / Low $ 14.66 / 13.90
- Stock P/E N/A
- Book Value 4.21
- EPS -1.40
- Next Earning Report 2026-08-05
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.15 %
- ROE -0.30 %
- 52 Week High 23.75
- 52 Week Low 10.95
About
Schrdinger, Inc. provides a physics-based software platform that enables the discovery of novel molecules for drug development and material applications. The company is headquartered in New York, New York.
Analyst Target Price
$20.88
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-05-05 | 2026-02-25 | 2025-11-05 | 2025-08-06 | 2025-05-07 | 2025-02-26 | 2024-11-12 | 2024-07-31 | 2024-05-01 | 2024-02-28 | 2023-11-01 | 2023-08-02 |
| Reported EPS | -0.62 | -0.1802 | -0.57 | -0.65 | -0.64 | -0.24 | -0.87 | -0.74 | -0.76 | -0.41 | -0.7 | -0.6 |
| Estimated EPS | -0.57 | -0.195 | -0.74 | -0.64 | -0.81 | -0.38 | -0.63 | -0.89 | -0.74 | -0.38 | -0.69 | -0.38 |
| Surprise | -0.05 | 0.0148 | 0.17 | -0.01 | 0.17 | 0.14 | -0.24 | 0.15 | -0.02 | -0.03 | -0.01 | -0.22 |
| Surprise Percentage | -8.7719% | 7.5897% | 22.973% | -1.5625% | 20.9877% | 36.8421% | -38.0952% | 16.8539% | -2.7027% | -7.8947% | -1.4493% | -57.8947% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-08-05 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | -0.6 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: SDGR
2026-06-11 21:10:31
Schrodinger, Inc. (SDGR) reported a wider-than-expected loss for the first quarter of 2026, while also missing revenue estimates. The company posted a loss of $0.66 per share, compared to the Zacks Consensus Estimate of a $0.57 per share loss, and revenue of $42.6 million, falling short of the $43.9 million projection. Management reaffirmed its full-year 2026 revenue guidance.
2026-06-10 21:10:05
Schrödinger, Inc. has finalized a transition agreement with its former Chief Commercial Officer, Mannix Aklian, formalizing a previous leadership change. The agreement includes salary continuation for nine months, subsidized health coverage, bonus payments totaling $88,096, and accelerated vesting of stock units in exchange for customary releases and restrictive covenants. This move aligns with Schrödinger's governance practices and aims to minimize operational disruption during the leadership transition.
2026-06-09 09:10:30
Schrodinger, Inc. (NASDAQ:SDGR) has finalized a transition and separation agreement with its former Chief Commercial Officer, Mannix Aklian, following his departure from the company. The agreement outlines severance payments, COBRA premiums, and prorated bonuses totaling $88,096, along with accelerated vesting of some restricted stock units. Additionally, the agreement includes mutual releases of claims and ongoing confidentiality obligations for Mr. Aklian.
2026-06-08 20:09:59
Schrodinger, Inc. (NASDAQ:SDGR) has finalized a separation agreement with its former Chief Commercial Officer, Mannix Aklian, outlining the terms of his departure. The agreement includes salary continuation, COBRA premiums, various bonus payments totaling $88,096, and accelerated vesting of some restricted stock units. Additionally, the company recently reported mixed Q1 2026 earnings and an analyst report highlighted AI's potential to significantly reduce drug development costs.
2026-06-08 20:09:59
Schrodinger (SDGR) has confirmed the separation of Mannix Aklian from his role as Chief Commercial Officer, Global Head of Software Sales and Marketing. The company detailed a separation agreement outlining specified payments and benefits. This change was effective June 5, 2026, following a previously disclosed separation.
2026-06-08 20:09:59
Schrödinger, Inc. (NASDAQ: SDGR) has detailed the separation terms for its former Chief Commercial Officer, Mannix Aklian, which align with his previous employment and severance agreements. Aklian will receive nine months of base-salary continuation, up to 12 months of company-paid COBRA premiums, and cash bonuses totaling $88,096 before taxes for quarters worked in 2026. Additionally, a portion of his July 2026 restricted stock unit tranche will see accelerated vesting, with all benefits contingent on his non-revocation of the agreement and adherence to ongoing confidentiality and non-solicitation obligations.
